Log In
Print this Print this


Also known as: 1014802

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionSodium channel blocker
Molecular Target Sodium channel
Mechanism of ActionNa channel blocker
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationBipolar disorder
Indication DetailsTreat bipolar disorder
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today